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ABSTRACT 
The present meta-analysis aimed to evaluate the relationship between body mass index (BMI) and rheumatoid  
arthritis (RA). A systematic search of the Cochrane, Pubmed, and Embase databases was conducted to identify 
relevant studies published before September 2017 using terms related to BMI and RA. Fixed or random-effect 
models were used to estimate the pooled relative risk (RR) with 95 % confidence interval (CI). Subgroup anal-
yses by sex were performed to investigate the association between BMI and RA in male and female subgroups. 
A total of 14 eligible studies containing 353,948 patients were included in the analysis. The pooled results sug-
gested that the odds ratios (ORs) of RA were 1.08 (95 % CI: 1.00~1.15) for overweight, and 1.32 (95 % CI: 
1.11~1.54) for obesity, respectively, suggesting that a higher BMI increases the risk of RA compared to normal 
weight. Further subgroup analyses showed a positive association between BMI and RA risk but only in females, 
with a RR of 1.11 (95 % CI: 1.00~1.22) for overweight and 1.40 (95 % CI: 1.24~1.57) for obesity. In conclu-
sion, an increased BMI may lead to a higher risk for RA development. Furthermore, the positive association be-
tween BMI and RA risk may be stronger in female populations than in males. However, additional analyses are 
needed. 
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INTRODUCTION 
Rheumatoid arthritis (RA), a common 
chronic autoimmune disease, is characterized 
by chronic, destructive, debilitating arthritis 
(Gabriel et al. 1999). The incidence rate of 
adult RA worldwide is about 1 %, but the 
proportion of infected women is far higher 
than that of men (Alamanos and Drosos, 
2005; Begovich et al., 2004). Thus far, the 
exact etiology and pathogenic mechanisms 
underlying RA remain unknown, but interac-
tions between genetic and environmental fac-
tors are generally accepted to be implicated 
in the susceptibility and severity of this 
complicated disorder. RA has been proven to 
have a familial component, which exerts 
about 15 % concordance and 53-65 % herit-
ability in twin studies (MacGregor et al., 
2000; Silman et al., 1993). Despite a high 
genetic susceptibility, the disease must also 
be influenced by environmental factors. The 
best support for this is the low concordance 
for RA in monozygotic twins (WHO, 2000). 
Candidate risk factors that participate in the 
initiation of this disease include age, gender, 
obesity, cigarette smoking, hormone levels, 
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psychological factors, alcohol consumption, 
and dietary habits, among others (Jin et al., 
2014; Parks et al., 2013; Voigt et al., 1994). 
As the quality of life of the general popu-
lation improves, obesity has become a com-
mon serious health problem affecting many 
people. The percent of overweight (body 
mass index (BMI) > 25 kg/m2) or obese 
(BMI > 30 kg/m2) individuals in the USA is 
estimated to be two thirds of the adult popu-
lation and one third of children (Barry et al., 
2012). In general, being overweight, as de-
termined by body mass index (BMI), is char-
acterized by abnormal accumulation of adi-
pose tissue that can accelerate the physiolog-
ical and pathological processes associated 
with various inflammatory/autoimmune con-
ditions due to immunomodulating and proin-
flammatory properties (Fantuzzi, 2005; Ver-
sini et al., 2014). Therefore, excess body 
weight may increase the risk of inflammato-
ry diseases that have high morbidity and 
mortality, such as RA (Bastard et al., 2000). 
According to relevant reports, more than 
50 % of RA patients are accompanied by 
obesity (Uhlig et al., 1999). In addition, nu-
merous studies have suggested that obesity is 
a potential promoter in the development and 
progression of RA (Crowson et al., 2013; 
Harpsøe et al., 2014; Lahiri et al., 2014; 
Ljung and Rantapää-Dahlqvist, 2016; Sym-
mons et al., 1997; Uhlig et al., 1999). This 
problem of obesity combined with the result-
ing metabolic syndrome in patients with RА 
has attracted extensive research attention 
(Symmons et al., 1997). 
Although many studies have focused on 
determining the association of body mass in-
dex (BMI) and RA risk, conflicting results 
have been obtained and clarification is need-
ed. Several previous studies have proposed a 
positive correlation between high BMI and 
increased risk of RA development, suggest-
ing that obesity is a key modifiable risk fac-
tor for RA (García-Poma et al., 2007; Uhlig 
et al., 1999). Conversely, other studies yield-
ed contrary results (Cerhan et al., 2002; 
Rodríguez et al., 2009; Wesley et al., 2013). 
Furthermore, some studies conclude that in-
creased BMIs contribute to a poor RA out-
comes (Hashimoto et al., 2009), whereas 
others have reported that a high BMI may be 
associated with less radiographic joint dam-
age (García-Poma et al., 2007). To further 
determine the impact of BMI on the devel-
opment of RA in a quantitative manner, as 
well as to explore BMI and the risk of RA in 
male and female subgroups, a meta-analysis 
was performed based on the available rele-
vant literature. 
 
METHODS 
Search strategy 
To identify all eligible studies regarding 
the association between BMI and risk of RA, 
two investigators independently performed 
an electronic search in the Cochrane, Pub-
med, and Embase databases up to September 
2017. The MeSH terms were as follows: 
“Rheumatoid Arthritis” or “Rheumatoid Ar-
thritis” combined with “Obesity” or “Obesi-
ty” or “Body Mass Index” or “Body Mass 
Index” or “Overweight”. All articles were 
limited to those published in the English lan-
guage, but without other restrictions on eth-
nicity, geographic regions, or human sub-
jects. The relevant articles from the initial 
search were further analyzed to identify the 
final qualified studies. If a disagreement oc-
curred, it was resolved through the involve-
ment of a third investigator. 
 
Inclusion and exclusion criteria 
A study was included if it met the fol-
lowing criteria: (1) case-control or cohort de-
sign; (2) the exposures of interest were BMI, 
obesity, or overweight; (3) the prevalence of 
RA was defined by physicians or the record 
linkage system, which was deemed as the 
outcome of interest; (4) the data included 
relative risk (RR) or odds ratios (ORs) with 
95 % confidence intervals (CIs); (5) pub-
lished in English language. If more than one 
article was published on the same or over-
lapping populations, the most recent one 
with the largest sample size or most detailed 
information was selected. A study was ex-
cluded in case of: (1) repeating publications, 
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or studies with similar content; (2) review, 
case report, theoretical research, mechanism 
studies, conference report, systematic re-
view, meta-analysis, unpublished, expert 
comment, theoretical analysis, or non-human 
studies; (3) the BMI was not grouped by 
normal weight, overweight, and obesity clas-
sifications from the WHO; (4) did not have 
sufficient published data or original data. All 
the studies were screened by two reviewers 
independently to determine whether they sat-
isfied the inclusion and exclusion criteria and 
discrepancies were resolved by discussion 
with a third reviewer. 
 
Data extraction and quality assessment 
Two investigators were responsible for 
data extraction, and the accuracy check was 
conducted by a third investigator. The BMI 
categories and RA risk estimates, including 
relative risk (RR) or odds ratios (ORs) with 
their 95 % CIs, were regarded as the primary 
variables of interest. RR or ORs from the 
maximally adjusted model was used to re-
duce the possibility of potential residual con-
founding. For each included study, data in-
cluding the author name, publication year, 
study design, the number of patients, age of 
participants, and gender were extracted. The 
results were reviewed by two independent 
reviewers, and any disagreements were re-
solved by discussion with a third reviewer 
until a consensus was reached. 
 
Statistical analysis 
According to World Health Organization 
guidelines (WHO, 2000), individuals with a 
BMI of 25~30 kg/m2 are classified as over-
weight and those with a BMI ≥ 30 kg/m2 are 
characterized as obese. This meta-analysis 
was conducted to compare RA risk in obesi-
ty/overweight and normal BMI individuals. 
Stata Version 12.0 software (Stata Corp, 
College Station, TX, USA) was used for all 
statistical analyses. Chi-squared and I2 tests 
were used to determine the significance of 
heterogeneity and identify the analysis mod-
el used for association: fixed-effect or ran-
dom-effect model (Higgins et al., 2005). A 
fixed-effect model was used to estimate 
pooled RRs with 95 % CIs when the Chi-
squared test P-value was ≤ 0.05 and I2 test-
value was > 50 %; otherwise, a random-
effect model was selected (DerSimonian and 
Nan, 1986). Subgroup analyses by sex were 
performed to investigate the association in 
male and female subgroups. All categorical 
data are presented as mean differences and 
analyzed by OR and 95 % CI. A P value of < 
0.05 was considered to be the threshold for 
statistical significance. 
 
RESULTS 
Study selection 
A total of 811 relevant studies were iden-
tified in the initial comprehensive literature 
search using index words. After screening 
the title or abstract, 758 articles were dis-
carded as duplicates and 53 articles remained 
for full-text evaluation. After reviewing the 
complete manuscript, 39 articles were ex-
cluded due to following reasons: rest or ex-
ercise analysis (4), without clinical outcomes 
(12), no-qualified grouping (16), theoretical 
research (7). Only 14 studies (Crowson et al., 
2013; Harpsøe et al., 2014; Lahiri et al., 
2014; Ljung and Rantapää-Dahlqvist, 2016; 
Lu et al., 2014; Palmer and Clegg, 2015; 
Pedersen et al., 2006; Rodríguez et al., 2009; 
Sparks et al., 2014; Symmons et al., 1997; 
Turesson et al., 2016; Uhlig et al., 1999; 
Voigt et al., 1994; Wesley et al., 2013) that 
satisfied all of the inclusion criteria were in-
cluded in this meta-analysis. A flow diagram 
of this selection process is shown in Figure 
1. 
 
Characteristics of the included studies 
The general characteristics of included 
studies are summarized in Table 1, which in-
cludes the first author of the study, publica-
tion year, study design, the number of pa-
tients, the average age of participants, and 
gender information. In total, 14 studies with 
a total of 353,948 patients were included in 
the analysis. All eligible articles were pub-
lished in English, and 9 articles were pub-
lished after 2010. Ten studies were designed 
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as case-control studies and four studies were 
cohort studies. Five studies reported the av-
erage age of both groups, and most patients 
were aged older than 50 years. Five studies 
were conducted in female populations and 
five studies were conducted in male popula-
tions, while four studies did not record gen-
der information. 
 
Figure 1: Flow diagram of the literature search and selection process 
 
 
 
Table 1: Basic characteristics of the included studies 
Study Design No. of patients Age Gender 
T C T C T C 
Wesley 2013 Case-control 2748 3444 - - 786M 976M 
Pedersen 2006 Case-control 515 769 - - 149M 291M 
Voigt 1994 Case-control 349 1457 - - - - 
Lahiri 2014 Case-control 184 25271 - - 56M 11499M
Lu 2014 Cohort study 109896  - - - 
Harpsøe 2014 Cohort study 75008 30.2 - 75008F - 
Crowson 2013 Case-control 813 813 55.9 55.9 556F 556F 
Uhlig 1999 Case-control 361 5830 - - 262F 3105F 
Symmons 1997 Case-control 165 178 49 49 50M 63M 
Rodríguez 2009 Case-control 559 4234 - - 159M 1132M 
Palmer 2015 Cohort study 52809  - -  
Ljung 2016 Case-control 557 1671 51.9 51.9 379F 1137F 
Turesson 2016 Case-control 172 688 58 58 136F 544F 
Sparks 2014 Cohort study 65457 - - - - 
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Overweight and risk of RA 
Data from 12 studies (9 case-control 
studies, 3 cohort studies) with 299,513 par-
ticipants were pooled to evaluate the associa-
tion between being overweight and the risk 
of RA. A fixed-effect model was used to an-
alyze the association based on the Chi-
squared test P-value (P = 0.546) and I2 test 
value (I2 = 0.0 %). The pooled results sug-
gested that being overweight could lead to a 
significant increase in RA risk compared 
with normal weight (OR: 1.08, 95 % CI: 
1.00~1.15, Figure 2).  
In the subgroup analysis, the association 
of male and female subgroups with RA risk 
was investigated. Four studies were available 
for identifying the association between being 
overweight and risk of RA in males. Signifi-
cant heterogeneity (I2 = 37.3 %, P = 0.188) 
did not exist, therefore, a fixed-effect model 
was used. As expected, no significant differ-
ence in the risk of RA was found between 
overweight and normal weight males (OR: 
0.80, 95 % CI: 0.58~1.02, Figure 3). Mean-
while, seven studies were available for ana-
lyzing the association between being over-
weight and risk of RA in females. No signif-
icant heterogeneity was found (I2 = 0.0 %, P 
= 0.856), and thus a fixed-effect model was 
used for the analysis. The results indicated 
that the risk of RA was significantly higher 
in overweight females than in normal weight 
females (OR: 1.11, 95 % CI: 1.00~1.22, Fig-
ure 3), suggesting that being overweight has 
a positive association with the risk of RA in 
females.
 
 
Figure 2: Forest plot showing the risk of rheumatoid arthritis for overweight compared to normal 
weight 
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Figure 3: Forest plot showing the risk of rheumatoid arthritis for overweight compared to normal 
weight in subgroup analyses 
 
 
Obesity and risk of RA 
13 studies (10 case-control studies, 3 co-
hort studies) containing data on 301,139 par-
ticipants reported the association between 
obesity and risk of RA. Based on the Chi-
squared test P-value (P = 0.000) and I2 tests-
value (I2 = 70.8 %), a random-effect model 
was used to analyze the association. Com-
pared to normal weight individuals, obesity 
significantly increased the risk of RA (OR: 
1.32, 95 % CI: 1.11~1.54, Figure 4).  
In the subgroup analysis, the association 
of male and female subgroups with RA risk 
was evaluated. Four studies reported the as-
sociation between obesity and risk of RA in 
males. There was significant heterogeneity 
(I2 = 79.5 %, P = 0.002), therefore the asso-
ciation was assessed using a random-effect 
model. No significant difference in the risk 
of RA (OR: 0.89, 95 % CI: 0.01~1.77, Fig-
ure 5) was found between obese and normal 
weight males. Eight studies were available 
for investigating the association between 
obesity and risk of RA in females. No signif-
icant heterogeneity was seen (I2 = 0.0 %, P = 
0.470), therefore, a fixed-effect model was 
applied. In the pooled results, a significantly 
higher risk of RA was found in obese fe-
males compared to normal weight females 
(OR: 1.40, 95 % CI: 1.24~1.57, Figure 5), 
suggesting that obesity may increase the risk 
of RA, especially in females. 
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Figure 4: Forest plot showing the risk of rheumatoid arthritis for obesity compared to normal weight 
 
 
DISCUSSION 
Rheumatoid arthritis (RA) is a common 
chronic autoimmune disease and has been 
shown to be the consequence of a combina-
tion of genetic and environmental factors. 
Environmental risks including age, gender, 
obesity, cigarette smoking, alcohol consump-
tion, and dietary habits, have been shown to 
be closely associated with the occurrence of 
this disorder (Di et al., 2014; Jin et al., 2014; 
Parks et al., 2013; Voigt et al., 1994). As an 
important potential risk factor, obesity and 
its association with RA development has 
been explored in several previous studies; 
however, the exact relationship remains 
poorly understood. In this study, we con-
ducted a meta-analysis to confirm the associ-
ation of BMI with RA development based on 
the current literature. The findings of this 
study indicated that BMIs indicating over-
weight or obesity are risk factors for RA. 
Furthermore, women with high BMI are 
more likely to suffer from RA compared 
than men. 
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Figure 5: Forest plot showing the risk of rheumatoid arthritis for obesity compared to normal weight in 
subgroup analyses 
 
 
Twelve studies reporting the association 
between BMI with RA risk revealed a posi-
tive association between overweight BMIs 
and RA when pooled (OR: 1.08, 95 % CI: 
1.00~1.15). Further subgroup analysis 
showed that the OR for RA was higher in 
females (OR: 1.11, 95 % CI: 1.00~1.22) 
compared to males (OR: 0.80, 95 % CI: 
0.58~1.02). Meanwhile, thirteen studies re-
ported the association between obesity and 
risk of RA, and similar results were ob-
tained. Collectively, it can be concluded that 
being overweight or obese can lead to a 
higher risk of RA development. In addition, 
the incidence of RA in women with high 
BMI is much higher than that in men. Com-
pared with the findings of recent research, 
the results of this meta-analysis are similar. 
Qin et al. (2015) found a significantly in-
creased risk of RA in the categories of obese 
and overweight populations compared with 
individuals with normal weight. Further 
dose-response analysis indicated that there 
was a nonlinear association between the high 
levels of BMI and RA development, and that 
the estimated summary relative risk for a 5-
unit increment was 1.03 (95 % CI: 1.01 
~1.05). Feng et al. (2016) reported that the 
RR of RA in obesity cases was 16 % more 
than that in overweight cases, meanwhile, 
the risk of RA increased by 13 % for every 5 
kg/m2 increase in BMI. Further subgroup 
analyses showed that the effect of BMI on 
the occurrence of RA was related to sex and 
serological status. Notably, overweight/ 
obese females and seronegative individuals 
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were more likely to develop RA when com-
pared to those with normal BMI. Even 
though the exact mechanism by which an in-
creased risk of RA occurs in over-
weight/obese individuals remains unclear, 
there are several plausible explanations. 
First, obesity may strengthen the autoim-
mune response through multiple mecha-
nisms, such as increasing the secretion of ad-
ipokines (Versini et al., 2014). Second, obe-
sity could modify the influence of sex hor-
mones on the development of RA (Doran et 
al., 2004). Third, gene variation can also 
change the relationship between obesity and 
autoimmune diseases (Soltani-Arabshahi et 
al., 2010). However, follow-up studies are 
needed for verification of these hypotheses. 
The major strengths of this meta-analysis 
were as follows: First, this meta-analysis was 
based on a comprehensive literature search 
of several databases to identify all relevant 
comparative studies. Therefore, a very large 
number of RA cases were included in this 
study, which improved the reliability, statis-
tical power, and validity of our results. Sec-
ond, most of the included studies were pub-
lished in relatively high impact journals in 
recent years, which were of high-quality and 
contained more comprehensive content. De-
spite these strengths, several potential limita-
tions also should also be noted. First, the in-
cluded studies were limited to the English 
language and some qualified studies pub-
lished in other languages were excluded, as 
were some unpublished data; thus, some 
publication bias existed. Second, the study 
populations of the included studies were lim-
ited to North American and European popu-
lations, therefore data for other continents 
are lacking. The development of RA is influ-
enced by lifestyle, living environment, and 
economic development, thus, obesity or in-
creased BMI may have different effects on 
the incidence rate of this disease in different 
places around the world. Based on the above, 
further investigations should be performed to 
evaluate the association between BMI and 
RA in different regions of the world, such as 
Africa and Asia. Third, RA is a multifactori-
al disease governed by complex gene-
environment interactions and few researchers 
have reported on the influence of genetic fac-
tors. Therefore, we were unable to assess the 
effects of genetic factors on this disease. 
Fourth, further sensitivity analyses and pub-
lication bias analyses were unable to be per-
formed in this study due to the lack of de-
tailed information from the individual stud-
ies. 
This meta-analysis systematically as-
sessed the association between body mass 
index (BMI) and rheumatoid arthritis (RA) 
risk based on the relevant current literature. 
The results demonstrated that increased BMI 
(classified as overweight or obese) is associ-
ated with a higher risk of developing RA. 
Furthermore, the positive association be-
tween BMI and RA risk may be stronger in 
females than in males, emphasizing sex de-
pendency of RA. Despite these results, future 
work is needed to combine more risk factors 
in large prospective studies to reveal the 
mechanisms of gene–environment interac-
tions in the development of RA.  
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